Calmare Therapeutics Probability of Future Stock Price Finishing Under 1.0E-4
| CTTCDelisted Stock | USD 0.0001 0.00 0.00% |
Calmare |
Calmare Therapeutics Target Price Odds to finish below 1.0E-4
The tendency of Calmare Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 36.16 |
Based on a normal probability distribution, the odds of Calmare Therapeutics to move below current price in 90 days from now is about 36.16 (This Calmare Therapeutics probability density function shows the probability of Calmare Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Calmare Therapeutics has a beta of -20.83 suggesting as returns on its benchmark rise, returns on holding Calmare Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Calmare Therapeutics is expected to outperform its benchmark. In addition to that Calmare Therapeutics has an alpha of 86.6917, implying that it can generate a 86.69 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Calmare Therapeutics Price Density |
| Price |
Predictive Modules for Calmare Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Calmare Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Calmare Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Calmare Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Calmare Therapeutics is not an exception. The market had few large corrections towards the Calmare Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Calmare Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Calmare Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 86.69 | |
β | Beta against Dow Jones | -20.83 | |
σ | Overall volatility | 0.0006 | |
Ir | Information ratio | 0.29 |
Calmare Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Calmare Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Calmare Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Calmare Therapeutics is not yet fully synchronised with the market data | |
| Calmare Therapeutics has some characteristics of a very speculative penny stock | |
| Calmare Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Calmare Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Calmare Therapeutics reported the previous year's revenue of 1.17 M. Net Loss for the year was (3.83 M) with profit before overhead, payroll, taxes, and interest of 771.48 K. | |
| Calmare Therapeutics currently holds about 12.55 K in cash with (1.24 M) of positive cash flow from operations. |
Calmare Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Calmare Stock often depends not only on the future outlook of the current and potential Calmare Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Calmare Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 5.5 M | |
| Shares Float | 18.2 M |
Calmare Therapeutics Technical Analysis
Calmare Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Calmare Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Calmare Therapeutics. In general, you should focus on analyzing Calmare Stock price patterns and their correlations with different microeconomic environments and drivers.
Calmare Therapeutics Predictive Forecast Models
Calmare Therapeutics' time-series forecasting models is one of many Calmare Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Calmare Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Calmare Therapeutics
Checking the ongoing alerts about Calmare Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Calmare Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Calmare Therapeutics is not yet fully synchronised with the market data | |
| Calmare Therapeutics has some characteristics of a very speculative penny stock | |
| Calmare Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Calmare Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Calmare Therapeutics reported the previous year's revenue of 1.17 M. Net Loss for the year was (3.83 M) with profit before overhead, payroll, taxes, and interest of 771.48 K. | |
| Calmare Therapeutics currently holds about 12.55 K in cash with (1.24 M) of positive cash flow from operations. |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |